Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: US FDA Approves Koselugo, Bestows BTDs On Bavencio, Sotatercept

14 Apr 2020

• By Bridget Silverman

Keeping Track Feature image

Related Content

Keeping Track Of User Fee Decisions And Filings: Adakveo, Brukinsa And Fetroja Mark Massive Week Of Novel Approvals

17 Nov 2019

Array's Three Value Drivers Align With Pfizer's Three Oncology Pillars In $11.4bn Deal

18 Jun 2019

Acceleron Buoyed By Sotatercept’s Promise In PAH

28 Jan 2020

Alnylam Seeking Lumasiran Approvals Soon, But Has Two Rivals On Its Heels

18 Dec 2019

Related Companies

Genentech, Inc.

AstraZeneca PLC

Merck & Co., Inc.

Pfizer Inc.

Array BioPharma, Inc.

Alnylam Pharmaceuticals Inc.

Merck KGaA

Acceleron Pharma, Inc.

Additional Topics

United States Approvals Drug Review Regulation Review Pathway US FDA Performance Tracker BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.